Cancer

Immune checkpoint inhibitors

Antibodies that release the brakes on T cells (PD-1, PD-L1, CTLA-4) so the immune system attacks the tumour; they transformed melanoma, renal cell, lung and liver cancer and Hodgkin lymphoma, but can trigger autoimmune damage to any organ.

Mechanism of action

Molecular targets

Drugs in Immune checkpoint inhibitors

Anti-PD-1

Anti-PD-L1

Anti-CTLA-4

Therapeutic uses

Diseases it treats

Adverse effects

Contraindications by condition

Other cautions and interactions

Connected topics

Written from

Educational reference. Not medical advice, diagnosis or treatment.